Tourmaline Bio, Inc.$21.73 %
Analyst Rating: Hold
Stock Details
CEO
Sandeep C. Kulkarni
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
74
Address
27 West 24th Street, New York City, NY, 10010
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.
Top Competitors
Income Statement
Financials
Selected Year
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Tourmaline Bio, Inc. $21.73
$0
Min Forecast(+0% )
$249.61
Avg Forecast( +0% )
$325
Max Forecast(+0%)
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results